Elobixibat clinical trials
Also written A3309.
How each study uses elobixibat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 3 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 5
Ferring Pharmaceuticals (4) · Albireo (3) · Yokohama City University (3) · Michael Camilleri, MD (1) · International University of Health and Welfare (1)
Studies
Open first, then newest update. How each study uses elobixibat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- A Phase 2 Study of Elobixibat in Adults With NAFLD or NASHCompletedPhase 2AlbireoNCT04006145Written as ElobixibatHow we know
- Study of A3309 in Patients With DyslipidemiaCompletedPhase 2AlbireoNCT01069783Written as A3309How we know
- Elobixibat for Chronic Constipation Without Defecation DesireTerminatedPhase 4International University of Health and WelfareNCT05703464Written as Elobixibat 10mgHow we know
- Long-term Elobixibat for Chronic ConstipationStatus unknownPhase 4Yokohama City UniversityNCT04784780Written as Elobixibat 10mgHow we know
- Elobixibat for Chronic Constipation Without Defecation DesireStatus unknownPhase 4Yokohama City UniversityNCT05165199Written as Elobixibat 10mgHow we know
- Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseCompletedPhase 2Yokohama City UniversityNCT04235205Written as Elobixibat 10mg + cholestyramine powder 9g (cholestyramine 4g)How we know
- Effect of Ileal Bile Acid Transporter Inhibitor in Functional ConstipationCompletedPhase 2Michael Camilleri, MDNCT01038687Written as A3309How we know
- Study of Elobixibat (A3309) in Patients With Chronic Idiopathic ConstipationCompletedPhase 2AlbireoNCT01007123Written as A3309How we know
- Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic ConstipationCompletedPhase 3Ferring PharmaceuticalsNCT01895543Written as Elobixibat 10 mgHow we know
- Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic ConstipationTerminatedPhase 3Ferring PharmaceuticalsNCT01833065Written as Elobixibat 10 mg/dayHow we know
- 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic ConstipationTerminatedPhase 3Ferring PharmaceuticalsNCT01827592Written as Elobixibat 10 mgHow we know
- Elobixibat Colonic Motor Function StudyWithdrawnPhase 2Ferring PharmaceuticalsNCT02392546Written as elobixibatHow we know
Codes
What other systems call elobixibat · ClinicalTrials.gg INT006286
- MeSH (NLM) C581303elobixibatOne source NLM
- UNII (FDA) 865UEK4EJCELOBIXIBATConfirmed FDA, NLM, Wikidata
- Wikidata Q5367035elobixibatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171820ElobixibatOne source FDA
- DrugBank DB12486One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C581303 | elobixibat | One source NLM |
| UNII (FDA) | 865UEK4EJC | ELOBIXIBAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5367035 | elobixibat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171820 | Elobixibat | One source FDA |
| DrugBank | DB12486 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.